Dataset from A Study to Evaluate Immunogenicity and Safety of Boostrix When Co-administered With Fluarix in Subjects 19 Years of Age and Older

The current study will provide information for the use of Boostrix concomitantly with influenza vaccine in adults aged 19-64 years. This study will also provide safety and immunogenicity data in a cohort of adults aged greater than or equal to 65 years.

本研究将为19~64岁成人联合接种Boostrix与流感疫苗的临床应用提供相关信息。此外，本研究还将提供65岁及以上成人队列的安全性与免疫原性数据。